Forecast Period 
Market Size (Base Year) 
Market Size (Forecast Year)
CAGRGlobal Point of Care Infectious Disease Diagnostics Market, By Product (Consumables, Instruments, and Software and Services), Technology (Lateral Flow, Agglutination Assays, Flow-Through, Solid Phase), Application (HIV, Tropical Disease, Liver Disease, Inflammatory Disease, Respiratory Disease, Hospital Associated Infections, Sexual Health Disorders), End User (Hospitals, Healthcare Centers, Laboratories, Independent Diagnostic Centers, Home Care Settings), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Point of Care Infectious Disease Diagnostics Market
Global point of care infectious disease diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account from USD 1,470.72 million in 2020 to USD 4,290.48 million by 2028 growing at a CAGR of 14.32% in the above-mentioned forecast period.
The point of care infectious disease diagnostics basically deals with service and equipment provided to a patient instantly at the time and site of an encounter by providing accurate and timely guidance for actionable information. The major infectious diseases that can be tested using point of care services and efficient diagnostic tools are tuberculosis, HIV, hepatitis, influenza, sexually transmitted infections, dengue fever and malaria. The quick diagnosis of an infection helps patient by facilitating timely treatment and also reduces the chances of further disease transmission.
The increasing amount awareness related to the diseases (Tuberculosis, HIV, hepatitis, influenza, sexually transmitted infections, dengue fever and malaria) and other infectious disease across the globe is estimated to boost the growth of the market as the patients require immediate point of care services. Another emerging factor which plays significant role in driving the market are portable devices, easy access of point of care services in remote areas and less expensive price by the different market players to enhance the equipment for effective testing. The technological advancements in field of medical tools by the market players currently established are focused on constant upgradation of technologies to improve the quality of healthcare equipment being provided to the patients. However, the absence of accurate results due to lack of training in clinics and the lack of skilled healthcare professionals in under developed countries proves to restraint the growth of the market.
New opportunities such as decentralizing healthcare systems can improve the efficiency of treatment in market. The stringent regulatory landscape and improper healthcare infrastructure is a major challenge which might affect growth of the market negatively within the forecast period.
This point of care infectious disease diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research point of care infectious disease diagnostics market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Point of Care Infectious Disease Diagnostics Market Scope and Market Size
Point of care infectious disease diagnostics market is segmented on the basis of product, technology, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Global point of care infectious disease diagnostics market on basis of product is segmented into consumables, instruments and software and services.
- Based on technology, the point of care infectious disease diagnostics market is segmented into lateral flow, agglutination assays, flow-through and solid phase.
The application segment of the point of care infectious disease diagnostics market is segmented into HIV, tropical disease, liver disease, inflammatory disease, respiratory disease, hospital associated infections and sexual health disorders.
- On basis of by end user the point of care infectious disease diagnostics market is bifurcated hospitals, healthcare centers, laboratories, independent diagnostic centers, and home care settings.
Point of Care Infectious Disease Diagnostics Market Country Level Analysis
Point of care infectious disease diagnostics market is analyzed and market size insights and trends are provided by product, technology, application and end user as referenced above.
The countries covered in the point of care infectious disease diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
The dominating region in the point of care infectious disease diagnostics market is North America due to its increased amount of adoption of respective testing instruments in hospitals for meeting the demand of point of care diagnostics for increasing number of cases various infective diseases. Moreover, the proper availability of healthcare and the medical facilities, the high awareness related to the diagnostics and availability of high skilled professionals are also major factors which make this region the most dominant. On the other hand, Asia-Pacific region is emerging as a lucrative market as it is projected to register the highest CAGR within the forecast period of 2021 to 2028 due to the developing healthcare infrastructure and other medical investments.
The country section of the point of care infectious disease diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Point of care infectious disease diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for point of care infectious disease diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point of care infectious disease diagnostics market. The data is available for historic period of 2010 to 2019.
Competitive Landscape and Global Point of Care Infectious Disease Diagnostics Market Share Analysis
Point of care infectious disease diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to point of care infectious disease diagnostics market.
The major players covered in the point of care infectious disease diagnostics market report are Siemens Healthcare GmbH, Trivitron Healthcare, F. Hoffmann-La Roche Ltd, Abbott, Quest Diagnostics Incorporated , BD, Chembio Diagnostics Inc., Trinity Biotech, Cardinal Health, Bio-Rad Laboratories Inc., bioMérieux SA, Thermo Fisher Scientific Inc., Ortho-Clinical Diagnostics, and OJ-Bio Limited., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
